April's Insider Flow简体 · 繁體
醫療保健 · Healthcare

SYRE · Spyre Therapeutics, Inc.

內部人交易(Form 4)· Insider trading · 2026-07-01 – 2026-10-22

Spyre Therapeutics, Inc.(SYRE)內部人交易:2026-07-01 至 2026-10-22,內部人公開市場買入 —、賣出 $19.6M;高管董事有效買入 —、有效賣出 —。最近申報 2026-10-02。

買入 Bought—
賣出 Sold$19.6M
有效買入 Effective bought—
有效賣出 Effective sold—
開啟互動頁面(K 線、成交價圖)Open interactive page →

最近申報 Recent filings

交易日內部人類型股數價格金額
2026-09-30Burrows Scott L
Chief Financial Officer
賣出 Sell25,000$90.47$2.3MSEC
2026-10-01King-Jones Heidy
See Remarks
賣出 Sell28,933$91.03$2.6MSEC
2026-10-01Turtle Cameron
Chief Executive Officer, Director
賣出 Sell15,000$92.01$1.4MSEC
2026-09-01Burrows Scott L
Chief Financial Officer
賣出 Sell25,732$88.75$2.3MSEC
2026-09-01King-Jones Heidy
See Remarks
賣出 Sell28,399$87.35$2.5MSEC
2026-09-01Turtle Cameron
Chief Executive Officer, Director
賣出 Sell15,000$87.29$1.3MSEC
2026-08-07Albers Jeffrey W.
Director
賣出 Sell23,000$104.53$2.4MSEC
2026-08-03Burrows Scott L
Chief Financial Officer
賣出 Sell7,500$95.57$717KSEC
2026-08-03Turtle Cameron
Chief Executive Officer, Director
賣出 Sell15,000$95.51$1.4MSEC
2026-07-01Burrows Scott L
Chief Financial Officer
賣出 Sell7,500$87.74$658KSEC
2026-07-01Sloan Sheldon
Chief Medical Officer
賣出 Sell8,334$87.70$731KSEC
2026-07-01Turtle Cameron
Chief Executive Officer, Director
賣出 Sell15,000$87.69$1.3MSEC
「有效」= 高管或董事的公開市場主動買賣,排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。

擬出售 Form 144

預計出售日申報人股數約金額
2026-10-01Turtle Cameron
Director, Officer
45,000$4.0M10b5-1
2026-10-01King-Jones Heidy
Officer
29,335$2.6M10b5-1
2026-09-30Burrows Scott L
Officer
17,500$1.6M
2026-09-01King-Jones Heidy
Officer
46,665$4.2M10b5-1
2026-08-07Albers Jeffrey W.
Director
18,000$1.9M10b5-1
2026-08-07Albers Jeffrey W.
Director
5,000$517K10b5-1
2026-08-03Burrows Scott L
Officer
30,000$2.9M10b5-1
2026-07-01Turtle Cameron
Director, Officer
45,000$4.0M10b5-1

內部人 Insiders

Burrows Scott L、King-Jones Heidy、Turtle Cameron、Albers Jeffrey W.、Sloan Sheldon